Shop
eStoreRx™
Online Supplement Dispensary
Easy direct-to-patient ordering & fulfilment for Lifelong Wellness, eStoreRx™ is offered as part of the WholePractice membership or as a stand-alone program.
For over 40 years, Biotics Research Corporation has revolutionized the nutritional supplement industry by utilizing “The Best of Science and Nature”. Combining nature’s principles with scientific ingenuity, our products magnify the nutritional
This inclusive membership contains all of the the tools you need to grow your business, including WholeLifeRx™, Nimativ®, WholeLifeQ™, eStoreRx™ and Practice Success Programs.
Easy direct-to-patient ordering & fulfilment for Lifelong Wellness, eStoreRx™ is offered as part of the WholePractice membership or as a stand-alone program.
April 18 2024
Results of a large population-based observational cohort study examining the association between weight loss and diabetes remission were recently publ...
A new economic modeling study published in Frontiers in Pharmacology last month explored how probiotics can be used to reduce healthcare costs while "instilling a spirit of proactivity for healthcare providers". Acute respiratory tract infections (RTI), pose a heavy burden on the US healthcare system and society at large. The study took the form of two large meta-analyses that investigated the effect of healthy subjects taking probiotics and compared the incidence and duration of RTIs. The paper also outlined that 61% of healthcare providers are routinely prescribing probiotic foods and supplements, alongside medications.
The findings of the study led by nutrition economist, Irene Lenoir-Wijnkoop, could positively impact productivity and healthcare expenses in the US. Lenoir-Wijnkoop’s economic analysis compared probiotic intake and no probiotic intake by using the state-transition microsimulation model. They found that the changes were small at an individual level, but if applied to the US population at large, there would be a significant impact on missed days of work and an estimated 19,012,000 to 54,491,000 fewer RTIs according to the Cochrane scenario.
The studies included the meta-analysis of Lactobacillus and Bifidobacterium bacterial strains. Further clinical trials on different strains of probiotics and strain levels are warranted.
Related Biotics Research Products:
Submit this form and you'll receive our latest news and updates.
Results of a small pilot study published in May 2023 in Neuroscience explored connections between the gut microbiome and...
Learn moreIn Genome Medicine, Harvard researchers recently published their analysis of metagenomic profiling of the gastrointestin...
Learn moreA growing body of evidence points to the intestinal microbiome as an important factor in both the initiation and metasta...
Learn more
*These statements have not been evaluated by the Food and Drug Administration. This product has not intended to diagnose, treat, cure, or prevent any disease.
© 2023 Biotics Research Corporation - All Rights Reserved
Submit your comment